Hilliquin, P., Barnetche, T., Baillet, A., Flipo, R., Lespessailles, E., Roux, C., . . . Saraux, A. (2020). Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study. Rheumatol Ther.
Chicago-tyylinen lähdeviittausHilliquin, Pascal, et al. "Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients With Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study." Rheumatol Ther 2020.
MLA-viiteHilliquin, Pascal, et al. "Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients With Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study." Rheumatol Ther 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.